Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Targeted deletion of Vegfa in adult mice induces vision loss
Toshihide Kurihara, … , Edith Aguilar, Martin Friedlander
Toshihide Kurihara, … , Edith Aguilar, Martin Friedlander
Published October 24, 2012
Citation Information: J Clin Invest. 2012;122(11):4213-4217. https://doi.org/10.1172/JCI65157.
View: Text | PDF
Brief Report Article has an altmetric score of 11

Targeted deletion of Vegfa in adult mice induces vision loss

  • Text
  • PDF
Abstract

Current therapies directed at controlling vascular abnormalities in cancers and neovascular eye diseases target VEGF and can slow the progression of these diseases. While the critical role of VEGF in development has been well described, the function of locally synthesized VEGF in the adult eye is incompletely understood. Here, we show that conditionally knocking out Vegfa in adult mouse retinal pigmented epithelial (RPE) cells, which regulate retinal homeostasis, rapidly leads to vision loss and ablation of the choriocapillaris, the major blood supply for the outer retina and photoreceptor cells. This deletion also caused rapid dysfunction of cone photoreceptors, the cells responsible for fine visual acuity and color vision. Furthermore, Vegfa deletion showed significant downregulation of multiple angiogenic genes in both physiological and pathological states, whereas the deletion of the upstream regulatory transcriptional factors HIFs did not affect the physiological expressions of angiogenic genes. These results suggest that endogenous VEGF provides critical trophic support necessary for retinal function. Targeting factors upstream of VEGF, such as HIFs, may be therapeutically advantageous compared with more potent and selective VEGF antagonists, which may have more off-target inhibitory trophic effects.

Authors

Toshihide Kurihara, Peter D. Westenskow, Stephen Bravo, Edith Aguilar, Martin Friedlander

×

Figure 2

Cone but not rod photoreceptor dysfunction in RPE-specific Vegfa mutants.

Options: View larger image (or click on image) Download as PowerPoint
Cone but not rod photoreceptor dysfunction in RPE-specific Vegfa mutants...
(A) Immunohistochemistry for rhodopsin (rods) and cone opsin (cones) 45 days after induction. Note that rhodopsin expression in Vegfa mutants is comparable to that observed in controls. (B) Optical coherence tomographic analysis indicates that retinal thicknesses remain relatively unchanged at all stages through 7 months. (C) Scotopic dark-adapted ERG captured in Vegfa mutants 3 or 7 days after induction. Note that no significant reduction in the a- and b-wave amplitudes is observed (n = 4). (D) Indocyanine green angiography for Vegfa mutants 45 days after induction. Note that choroidal circulation is significantly diminished in the mutants, while the retinal circulation is normal. (E) Electron micrograph of a cross-sectioned Vegfa mutant retina 14 days, 2 months, and 7 months after induction. Note that a few deep choroidal vessels are observed (asterisk). (F) mRNA array for angiogenic genes in Vegfa mutant RPE/choroids compared with controls 3 days after injection (n = 3). Fold-change (x axis) and P value (y axis) of gene expression compared with controls are shown. Note that 32 of 84 genes are significantly downregulated. Error bars indicate mean ± SD. Scale bars: 2,000 μm (D); 200 μm (B); 20 μm (A); 10 μm (E).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 1 news outlets
Posted by 4 X users
177 readers on Mendeley
See more details